|
|
|
|
|
|
Oriflame Cosmetics specializes in the design, manufacturing and marketing of cosmetic products. Net sales break down by family of products as follows:
- beauty products (24%): primarily makeup, coloring products, etc.;
- skin care products (21%);
- hygiene products (21%): body washes, shower gels, shampoo, soap, toothpaste, etc.;
- fragrances (20%);
- jewels and accessories (14%): rings, necklaces, watch, bags, etc.
The products are marketed through direct sales.
Net sales are distributed geographically as follows: Europe/Russia/Africa (83.5%), Asia (9.8%), Latin America (5.8%) and other (0.9%).
| |
| Surperformance© rating of Oriflame Cosmetics SA | |
|
|
Overall rating |
In sector |
In country |
| Trading Rating |
|
|
|
| Investor Rating |
|
|
|
| Growth (Revenue) |
|
|
|
| Valuation |
|
|
|
| Finances |
|
|
|
| Profitability |
|
|
|
| Earnings quality |
|
|
|
| Business Predictability |
|
|
|
| PER |
|
|
|
| Potential |
|
|
|
| Yield |
|
|
|
| Consensus |
|
|
|
| 7 days EPS revision |
|
|
|
| 4 months EPS revision |
|
|
|
| 1 year EPS revision |
|
|
|
| 4 months Revenue revision |
|
|
|
| 1 year Revenue revision |
|
|
|
| |
| |
|
|
Data source : © 2013 Thomson Reuters |
|
Ratings : © 2013 Surperformance |
|
|
|
|
|
| - Stichting af Jochnick Foundation |
10,70% |
| - Mister Jonas af Jochnick |
9,00% |
| - SSB CL Omnibus |
9,80% |
| - Mister Robert af Jochnick |
7,10% |
| - JP Morgan Chase Bank |
5,80% |
| - AMF Pension |
3,20% |
| - Andra AP-Fonden |
3,20% |
| - Oppenheimer |
1,50% |
|
|
|
|
- Chief Executive Officer : Magnus Brännström |
- Chief Financial Officer : Gabriel Bennet |
- Investor Relations : Patrik Linzenbold |
|
|
| Company contact information |
|
Philippe II rue 20 LU-2340 Luxembourg Sweden
Phone : +46 2 26 203 232 Fax : +46 2 26 203 234 Internet : http://www.oriflame.com
|
|
|
|
- NASDAQ OMX nordic Stockholm - Main Market Large |
|
|
|
|
| - ISIN Code : |
SE0001174889 |
| - Bloomberg Code : |
|
| - Reuters Code : |
ORIsdb.ST |
| - Datastream Code : |
|
|
Financial data source : © 2013 Cofisem |
|
|